Company Jafron Biomedical Co.,Ltd.
Equities
300529
CNE100002995
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
29.09 CNY | -1.09% | +5.63% | +30.86% |
Business Summary
Number of employees: 2,408
Sales per Business
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Disposable Blood Perfusion Device
76.4
%
| 2,025 | 81.3 % | 1,468 | 76.4 % | -27.50% |
Blood Purification Equipment
12.3
%
| 198 | 7.9 % | 236 | 12.3 % | +19.26% |
Disposable Plasma Bilirubin Absorber
4.8
%
| 115 | 4.6 % | 92 | 4.8 % | -20.13% |
Other
3.6
%
| 79 | 3.2 % | 70 | 3.6 % | -11.58% |
Hemodialysis Powder and Liquid Products
2.9
%
| 75 | 3.0 % | 57 | 2.9 % | -24.09% |
Sales per region
CNY in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
97.3
%
| 2,429 | 97.5 % | 1,870 | 97.3 % | -23.01% |
Overseas
2.7
%
| 62 | 2.5 % | 52 | 2.7 % | -16.32% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Fan Dong
CEO | Chief Executive Officer | 54 | 01/99/01 |
Yao Hong Chen
BRD | Director/Board Member | 45 | 01/13/01 |
Feng Li
BRD | Director/Board Member | 54 | 01/10/01 |
Xian Min Tang
BRD | Director/Board Member | 54 | 01/99/01 |
Cong Huang
SEC | Corporate Secretary | 32 | 01/19/01 |
De Zhi Li
PRN | Corporate Officer/Principal | 58 | 01/05/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Guo Qing Guo
BRD | Director/Board Member | 62 | 21/23/21 |
Yan Jun Xu
BRD | Director/Board Member | 51 | 21/23/21 |
Fan Dong
CEO | Chief Executive Officer | 54 | 01/99/01 |
Xian Min Tang
BRD | Director/Board Member | 54 | 01/99/01 |
Zhi Hao Wen
BRD | Director/Board Member | 58 | 25/13/25 |
58 | - | ||
Feng Li
BRD | Director/Board Member | 54 | 01/10/01 |
Xiao Hong Peng
CHM | Chairman | 64 | 15/17/15 |
Yao Hong Chen
BRD | Director/Board Member | 45 | 01/13/01 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 807,555,312 | 388,787,572 ( 48.14 %) | 31,364,079 ( 3.884 %) | 48.14 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
14,804,287 | 2.89% | 45,534,582 $ |
Company contact information
Sector
Sales per Business
Sales per region
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.86% | 3.16B | |
-3.54% | 184B | |
-0.58% | 109B | |
-2.74% | 68.37B | |
+4.84% | 51.56B | |
+10.40% | 44.69B | |
+4.28% | 41.49B | |
+2.87% | 26.75B | |
+4.61% | 26.7B | |
+14.15% | 25.68B |
- Stock Market
- Equities
- 300529 Stock
- Company Jafron Biomedical Co.,Ltd.